Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study

Irena Ćojbašić, Ivan Tijanić, Žarko Ćojbašić

Open source

DOI: 10.1590/1516-3180.2026.3647.06052026
Published: 2026
Container: Sao Paulo Medical Journal
Publisher: FapUNIFESP (SciELO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1590/1516-3180.2026.3647.06052026,
  title = {Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study},
  author = {Irena Ćojbašić and Ivan Tijanić and Žarko Ćojbašić},
  year = {2026},
  journal = {Sao Paulo Medical Journal},
  doi = {10.1590/1516-3180.2026.3647.06052026},
  url = {https://doi.org/10.1590/1516-3180.2026.3647.06052026}
}

RIS

TY  - JOUR
TI  - Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study
AU  - Irena Ćojbašić
AU  - Ivan Tijanić
AU  - Žarko Ćojbašić
PY  - 2026
JO  - Sao Paulo Medical Journal
DO  - 10.1590/1516-3180.2026.3647.06052026
UR  - https://doi.org/10.1590/1516-3180.2026.3647.06052026
ER  -

APA

Ćojbašić, I., Tijanić, I., & Ćojbašić, Ž. (2026). Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study. Sao Paulo Medical Journal. https://doi.org/10.1590/1516-3180.2026.3647.06052026

Source records

crossref · retrieved 2026-09-26T20:08:55.141Z